Novo Nordisk
NVO
461 hedge funds and large institutions have $8.34B invested in Novo Nordisk in 2014 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 149 increasing their positions, 180 reducing their positions, and 31 closing their positions.
103% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 31
65% more funds holding in top 10
Funds holding in top 10: 17 → 28 (+11)
39% more capital inflows, than outflows
Capital inflows: $672M | Capital outflows: $484M
7% more funds holding
Funds holding: 432 → 461 (+29)
0.15% more ownership
Funds ownership: 7.87% → 8.01% (+0.15%)
17% less repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 180
53% less call options, than puts
Call options by funds: $8.57M | Put options by funds: $18.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$166M |
| 2 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$101M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$43.1M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.5M |
| 5 |
Aperio Group
Sausalito,
California
|
+$23.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$108M |
| 2 |
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$70.8M |
| 3 |
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$37.1M |
| 4 |
Placemark Investments
Chicago,
Illinois
|
-$25.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$24.2M |
NVO Hedge Fund Activity: Q1 2014 in Review
461 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2014, worth a combined $8.34B — up 25% from $6.65B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new NVO positions and 31 closed out — a net gain of 32 holders — while 149 added to existing stakes and 180 trimmed.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $166M. The largest seller was WCM Investment Management, cutting an estimated $108M.
- 461 institutional investors held Novo Nordisk (NVO) as of Q1 2014, up from 432 in Q4 2013.
- Funds reported $8.34B of Novo Nordisk stock for Q1 2014, up 25% quarter-over-quarter.
- 63 funds opened new Novo Nordisk positions in Q1 2014 and 31 closed out, a net change of +32 holders.
- The largest Novo Nordisk buyer in Q1 2014 was Loomis, Sayles & Company, an estimated $166M added.
- The largest Novo Nordisk seller in Q1 2014 was WCM Investment Management, an estimated $108M sold.
Based on aggregated 13F filings for Q1 2014.